WAUKEGAN, Ill.--(BUSINESS WIRE)--Feb. 28, 2006--NeoPharm, Inc. (Nasdaq:NEOL) today announced financial results for the fourth quarter and fiscal year ended December 31, 2005. Fourth Quarter 2005 Results. The Company reported a fourth quarter 2005 net loss of approximately $9.7 million, or $0.41 per basic and diluted share. The fourth quarter loss represents a $4.9 million, or 33.6%, improvement compared to the $14.6 million loss, or $0.63 per basic and diluted share, in the fourth quarter of 2004. Additionally, the fourth quarter 2006 results also represent a $0.8 million improvement compared to the $10.5 million loss, or $0.45 per basic and diluted share, in the third quarter of 2005.
